The independent assessment results for Bard1 Ovarian testing...

The independent assessment results for Bard1 Ovarian testing should be being released very soon. Hopefully these are positive and then we move to clinical validation and commercial sales Q1 22. Not sure if I'm more excited about that or Exonet being released early next quarter or updates from Vivasome or Minomic collaborations or additional large volume sales of hTERT, or additional news about other highly specific results from Subb2m. We are truly spoilt for choice. With a 12 month view, this business is still clearly well undervalued IMO. With a 5 year view this is a life changing opportunity.

The 'market' is set up so that bigger players can manipulate the price to get in and take a position. It is massively irritating but hey; the rich make the rules to suit the rich; so not much we can do about it. At the end of the day, once they have their positions sorted we will have an uninterrupted blue sky in front of us.

For all these new BD1 owners/traders who have suddenly appeared on HC and flipped from FOMO to FONGO (Fear of Not Getting Out) in a heartbeat in the last couple of days. As Buffett once said, "If you aren't willing to own a stock for ten years, don't even think about owning it for ten minutes."